EU Hepatitis C Drugs Market, Market Segmented by Product type (NS5A Inhibitor (Protease Inhibitors), Fixed-dose Combination and Others), by Disease type (Acute Hepatitis C and Chronic Hepatitis C) and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) - Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138263
- Pages: 200
-
Format:
Report Overview
The EU Hepatitis C Drugs market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Hepatitis C is a liver infection that is caused due to the hepatitis C virus. The hepatitis C virus may cause both acute as well as chronic hepatitis. It is a bloodborne virus and is commonly infected through small quantities of blood
Market Drivers
Factors such as the high prevalence of hepatitis C and increasing awareness regarding the disease are expected to drive the market. Stringent government regulations and alternate treatment options, such as herbal treatment offered at comparatively lower prices are expected to hamper the market growth
1. EU Hepatitis C Drugs Market Overview..............................
A. Market Size
2. EU Hepatitis C Drugs Growth Drivers..........................
A. High prevalence of hepatitis C
B. Increasing Awareness regarding the disease
3. EU Hepatitis C Drugs Market Segmentation........
A. By Disease type
I. Acute Hepatitis C
II. Chronic Hepatitis C
B. By Product type
I. NS5A Inhibitors (Protease Inhibitors)
II. Fixed Combination
III. Others
C. By Distribution Channel
I. Hospital
II. Retail Pharmacies
III. Online Pharmacies
IV. Others
4. EU Hepatitis C Drugs Major Market Share........................
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Gilead Company overview, Product & Services, Strategies & Financials
B. Bristol Myers Squibb Company overview, Product & Services, Strategies & Financials
C. Merck Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
